The vaccine production line against cancer, heart diseases and MS was opened

According to the Fars news agency, citing the Media Center of the Judiciary, Hojjat-ul-Islam Mohseni Ajeei, the head of the judicial system, visited the Barkat pharmaceutical group in Alborz province this morning, Wednesday, July 15, and visited various parts of the complex.

In this visit, Hojjat-ul-Islam Mohseni Ajeei first attended the building of Shafa Pharmed company and was closely informed about the production process of Iran Barkat’s KV vaccine.

During this visit, the head of the Judiciary asked questions about the initiation of the research project for the production of the Iranbarakt vaccine and the establishment and location of the equipment for the production of this vaccine.

The head of the judicial system also considered the production of a local corona vaccine as one of the honors of the holy system of the Islamic Republic of Iran and said: The production of the Iranian corona vaccine gave confidence and strength to our youth and proved that despite the existence of many restrictions and pressures, a great and seemingly impossible task can be done. concluded

During this visit, the head of the research group for the production of the Iranian Corona vaccine of the executive headquarters of the order of the Imam (RA), while expressing the progress and capabilities of our country’s experts in the field of vaccine production, gave an explanation of the process of the production of the vaccine in Iran Barkat.

Stating that there is currently the capacity for any other type of virus to enter the country, a native vaccine can be made immediately and within a very short period of time, he said: from the time of the outbreak of the corona virus in the country until the clinical study of the first phase of the vaccine. About 11 months have passed since the introduction of Corona, but only 29 days have passed since the arrival of Amicron in the country until the production of its vaccine.

He also said that experts from the World Health Organization visited Iran’s Barkat vaccine production line in April this year and acknowledged the unique equipment of this production line and the high scientific value of this series of products in their report.

After this visit, with the presence of the head of the judicial system and the officials of the Barkat pharmaceutical group and the executive headquarters of Imam Khomeini’s decree, the vaccine production line of biologic and peptide products of Biosan Pharmed Company was opened.

After the inauguration of this production line, the Head of the Judiciary considered the subject of medicine, medicine and pharmaceuticals to be a very important category that mankind has needed since the beginning of its creation and this need continues.

Stating that the knowledge and science of drug production is not a knowledge that is used at one point in time and is not needed at another point in time, the head of the judiciary said that the process of drug production in the Barkat pharmaceutical group is a continuous process and is not temporary or fleeting. It is an important issue.

Hojjat-ul-Islam Mohseni Ajeei continued: The production of the Iranian Corona vaccine and the saving of human lives through the production of this medicine in a relatively short period, considering the oppressive pressures of sanctions, in addition to raising the level of our country in the world and among the most advanced countries in the field of production This type of vaccine made many people surprised.

The head of the Judiciary also emphasized: production of science and manufacturing of pharmaceutical products in various fields generates power for our country, and this power generation makes our country safe against the threats and enmities of enemies.

It is worth mentioning that Biosan Pharmed’s pharmaceutical products, whose production line was opened today in the presence of the head of the judiciary, are used in the fields of fighting cancer, cardiovascular diseases, MS, infertility and blood diseases.

It should be noted that, while most of the technical know-how for the production of biological products, peptides and vaccines is in the possession of a few advanced countries in the world, Biosan Pharmed Company as a knowledge-based company by using the production infrastructure and relying on the knowledge of internal researchers and experts is on par with other companies. The world’s leading pharmaceutical company has developed the technical know-how to produce these products.